WST WEST PHARMACEUTICAL SERVICES
2026Q1 · CUSIP 955306105 · Sector: Healthcare & Biotech
Fading · Price holds, watch
Holders
752
Δ holders QoQ
-50
Breadth percentile
Top 97%
Whale holders
284
Δ whales
-6
Inst. holding value
$17.5B
New positions
89
Closed positions
139
Price momentum (1Q)
+25.3%
Put / Call
7/9
Breadth history (34 quarters)
Past Lit Events & Aftermath 16 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 12% | +25.3% | — |
| 2025Q3 | Top 13% | -7.0% | +16.6% |
| 2025Q2 | Top 18% | +7.6% | +2.3% |
| 2023Q3 | Top 5% | +1.8% | -0.3% |
| 2023Q2 | Top 5% | -12.5% | -11.7% |
| 2023Q1 | Top 1% | +12.9% | -0.5% |
| 2021Q4 | Top 7% | -22.5% | -15.1% |
| 2021Q3 | Top 3% | -14.2% | -33.5% |
Options Sentiment
Put holders
7
QoQ: -2
Call holders
9
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
47.1
EPS (TTM)
$7.48
EPS YoY
+17.4%
Revenue (TTM)
$3.2B
Revenue YoY
+11.2%
Net margin
16.9%
ROE
18.1%
Debt ratio
27.2%
FCF (TTM)
$458M
Dividend (TTM)
$0.87
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.